Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentostatin and Targeted Busulfan Conditioning for Allogeneic HCT
NCT00496340Phase 2Completed
- Sponsor
- Moffitt Cancer Center
- Start
- Jul 2007
- Primary completion
- Apr 2013
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of pentostatin, busulfan in hematologic malignancy, sponsored by Moffitt Cancer Center. Started Jul 2007; status: completed.
02
Drugs
pentostatinbusulfan
03
Conditions
hematologic malignancy
Beyond the preview
Go deeper on NCT00496340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00496340.